标题
Considering patient age when treating multiple sclerosis across the adult lifespan
作者
关键词
-
出版物
Expert Review of Neurotherapeutics
Volume -, Issue -, Pages 1-12
出版商
Informa UK Limited
发表日期
2021-02-19
DOI
10.1080/14737175.2021.1886082
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis
- (2020) Burcu Zeydan et al. ANNALS OF NEUROLOGY
- Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study
- (2020) Robert T. Naismith et al. CNS DRUGS
- Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective
- (2020) Jakimovski et al. Vaccines
- Longitudinal Assessment of Multiple Sclerosis with the Brain‐Age Paradigm
- (2020) James H. Cole PhD et al. ANNALS OF NEUROLOGY
- Sex‐Specific Differences in Life Span Brain Volumes in Multiple Sclerosis
- (2020) Dejan Jakimovski et al. JOURNAL OF NEUROIMAGING
- Association between shorter leukocyte telomeres and multiple sclerosis
- (2020) Raneem Habib et al. JOURNAL OF NEUROIMMUNOLOGY
- Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States
- (2020) David M. Kern et al. BMC Neurology
- Comorbidity is associated with disease activity in MS
- (2020) Amber Salter et al. NEUROLOGY
- Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis
- (2020) Maria Pia Amato et al. BRAIN
- Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis
- (2020) Lara Marie Pangan Lo et al. JOURNAL OF NEUROLOGY
- Increasing cancer risk over calendar year in people with multiple sclerosis: a case–control study
- (2020) Chiara Zecca et al. JOURNAL OF NEUROLOGY
- Menopause and multiple sclerosis: Influence on prognosis and role of disease-modifying drugs and hormonal replacement therapy
- (2020) Luciana Midaglia et al. Multiple Sclerosis Journal
- Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis
- (2020) Aaron E. Miller et al. JAMA Neurology
- Late onset multiple sclerosis is associated with more severe ventricle expansion
- (2020) Dejan Jakimovski et al. Multiple Sclerosis and Related Disorders
- Differential Diagnosis of Cognitive Decline in Elderly Individuals With Multiple Sclerosis
- (2020) Dejan Jakimovski et al. Cognitive and Behavioral Neurology
- Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial
- (2020) Jerry S Wolinsky et al. LANCET NEUROLOGY
- Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis
- (2020) Franziska E. Hildesheim et al. Multiple Sclerosis and Related Disorders
- Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades
- (2019) Omid Beiki et al. JAMA Neurology
- Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis
- (2019) Alexandra M. Nicaise et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The prevalence of MS in the United States
- (2019) Mitchell T. Wallin et al. NEUROLOGY
- Telomeres and telomerase: three decades of progress
- (2019) Jerry W. Shay et al. NATURE REVIEWS GENETICS
- Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis
- (2019) Benjamin Turner et al. JOURNAL OF NEUROLOGY
- Epidemiology and treatment of multiple sclerosis in elderly populations
- (2019) Caila B. Vaughn et al. Nature Reviews Neurology
- Cognitive Profiles of Aging in Multiple Sclerosis
- (2019) Dejan Jakimovski et al. Frontiers in Aging Neuroscience
- Changes in patient-reported outcomes between continuers and discontinuers of disease modifying therapy in patients with multiple sclerosis over age 60
- (2019) Le H. Hua et al. Multiple Sclerosis and Related Disorders
- Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort
- (2019) Emanuele D'Amico et al. Frontiers in Neurology
- Cross-Sectional and Longitudinal MRI Brain Scans Reveal Accelerated Brain Aging in Multiple Sclerosis
- (2019) Einar A. Høgestøl et al. Frontiers in Neurology
- Age and the risks of high-efficacy disease modifying drugs in multiple sclerosis
- (2019) Finja Schweitzer et al. CURRENT OPINION IN NEUROLOGY
- Impact of natural menopause on multiple sclerosis: a multicentre study
- (2019) Damiano Baroncini et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Anticholinergic Drug Exposure and the Risk of Dementia
- (2019) Carol A. C. Coupland et al. JAMA Internal Medicine
- Thirty-day readmissions in multiple sclerosis: An age and gender-based US national retrospective analysis
- (2019) Smit Patel et al. Multiple Sclerosis and Related Disorders
- Preserved network functional connectivity underlies cognitive reserve in multiple sclerosis
- (2019) Tom A. Fuchs et al. HUMAN BRAIN MAPPING
- Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies
- (2019) Marisa P McGinley et al. Multiple Sclerosis Journal
- Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study
- (2019) Nina Grytten et al. Multiple Sclerosis Journal
- Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis
- (2019) Mauricio F. Farez et al. NEUROLOGY
- Telomere Length Is Associated with Disability Progression in Multiple Sclerosis
- (2019) Kristen M. Krysko et al. ANNALS OF NEUROLOGY
- Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
- (2019) Gustavo Luna et al. JAMA Neurology
- Alemtuzumab therapy changes immunoglobulin levels in peripheral blood and CSF
- (2019) Nora Möhn et al. Neurology-Neuroimmunology & Neuroinflammation
- Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study
- (2018) José Maria Andreas Wijnands et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
- (2018) Ludwig Kappos et al. LANCET
- Multiple sclerosis
- (2018) Alan J Thompson et al. LANCET
- Discontinuation of disease-modifying therapy in patients with multiple sclerosis over age 60
- (2018) Le H Hua et al. Multiple Sclerosis Journal
- Smoking affects the interferon beta treatment response in multiple sclerosis
- (2018) Eva R. Petersen et al. NEUROLOGY
- Discontinuation of disease-modifying therapy in patients with multiple sclerosis over age 60
- (2018) Le H Hua et al. Multiple Sclerosis Journal
- Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis
- (2018) Eva Rosa Petersen et al. Multiple Sclerosis Journal
- Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study
- (2018) Francesco Saccà et al. Multiple Sclerosis Journal
- Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
- (2018) Luigi Ferrucci et al. Nature Reviews Cardiology
- Inflammaging: a new immune–metabolic viewpoint for age-related diseases
- (2018) Claudio Franceschi et al. Nature Reviews Endocrinology
- Age is a critical determinant in recovery from multiple sclerosis relapses
- (2018) Brittani L Conway et al. Multiple Sclerosis Journal
- Ocrelizumab: a B-cell depleting therapy for multiple sclerosis
- (2017) Dejan Jakimovski et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathy
- (2017) Luca Prosperini et al. JOURNAL OF NEUROVIROLOGY
- Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biological sero-converters
- (2017) Nicholas Schwab et al. Multiple Sclerosis Journal
- Comorbidity in multiple sclerosis: implications for patient care
- (2017) Ruth Ann Marrie Nature Reviews Neurology
- Ovarian aging is associated with gray matter volume and disability in women with MS
- (2017) Jennifer S. Graves et al. NEUROLOGY
- Assessing association of comorbidities with treatment choice and persistence in MS
- (2017) Alice Laroni et al. NEUROLOGY
- Comorbidity increases the risk of relapse in multiple sclerosis
- (2017) Kaarina Kowalec et al. NEUROLOGY
- Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis
- (2017) Burhan Z. Chaudhry et al. Neurotherapeutics
- Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biological sero-converters
- (2017) Nicholas Schwab et al. Multiple Sclerosis Journal
- Classifying PML risk with disease modifying therapies
- (2017) Joseph R. Berger Multiple Sclerosis and Related Disorders
- Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments
- (2017) Ann Marie Weideman et al. Frontiers in Neurology
- Long-term evolution of multiple sclerosis disability in the treatment era
- (2016) et al. ANNALS OF NEUROLOGY
- Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype
- (2016) Christopher D. Wiley et al. Cell Metabolism
- Subgroup and sensitivity analyses of annualized relapse rate over 2 years in the ADVANCE trial of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis
- (2016) Scott D. Newsome et al. JOURNAL OF NEUROLOGY
- Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study
- (2016) Ilya Kister et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer risk
- (2016) Deeya Gaindh et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial
- (2016) Rhonda R Voskuhl et al. LANCET NEUROLOGY
- Discontinuation of disease-modifying therapies in multiple sclerosis – Clinical outcome and prognostic factors
- (2016) Gabriel Bsteh et al. Multiple Sclerosis Journal
- CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatment
- (2016) Yonghao Cao et al. NEUROLOGY
- Brain reserve against physical disability progression over 5 years in multiple sclerosis
- (2016) James F. Sumowski et al. NEUROLOGY
- Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis
- (2016) Tingting Zhang et al. NEUROLOGY
- Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients
- (2016) Mohammadhossein Hajiebrahimi et al. PLoS One
- Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment
- (2016) Jordan E Axelrad et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis
- (2016) Laura Negrotto et al. JAMA Neurology
- Discontinuation of disease-modifying therapies in multiple sclerosis – Clinical outcome and prognostic factors
- (2016) Gabriel Bsteh et al. Multiple Sclerosis Journal
- Subgroups of multiple sclerosis patients with larger treatment benefits: a meta-analysis of randomized trials
- (2015) A. Signori et al. EUROPEAN JOURNAL OF NEUROLOGY
- Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort
- (2015) Riley Bove et al. Multiple Sclerosis Journal
- Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis
- (2015) Martina Novotna et al. NEUROLOGY
- Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort
- (2015) Riley Bove et al. Multiple Sclerosis Journal
- Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
- (2014) Jeremy Chataway et al. LANCET
- Prevalence of Multimorbidity in a Geographically Defined American Population
- (2014) Walter A. Rocca et al. MAYO CLINIC PROCEEDINGS
- Patients with multiple sclerosis show increased oxidative stress markers and somatic telomere length shortening
- (2014) Jing-Zhi Guan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- A systematic review of the incidence and prevalence of cancer in multiple sclerosis
- (2014) Ruth Ann Marrie et al. Multiple Sclerosis Journal
- Relapses and disability accumulation in progressive multiple sclerosis
- (2014) M. M. Paz Soldan et al. NEUROLOGY
- Btk Regulates Macrophage Polarization in Response to Lipopolysaccharide
- (2014) Joan Ní Gabhann et al. PLoS One
- Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: subgroup analyses of the CONFIRM study
- (2013) Michael Hutchinson et al. JOURNAL OF NEUROLOGY
- Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: subgroup analyses of the DEFINE study
- (2013) Amit Bar-Or et al. JOURNAL OF NEUROLOGY
- Smokers run increased risk of developing anti-natalizumab antibodies
- (2013) AK Hedström et al. Multiple Sclerosis Journal
- Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers
- (2013) Mohsen Khademi et al. PLoS One
- Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice
- (2012) L. P. Kil et al. BLOOD
- NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury
- (2012) Marie T. Fischer et al. BRAIN
- Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study
- (2012) Virginia Devonshire et al. LANCET NEUROLOGY
- Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis
- (2012) Aaron E Miller et al. Multiple Sclerosis Journal
- Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis
- (2012) M. Tutuncu et al. Multiple Sclerosis Journal
- Telomere length in early life predicts lifespan
- (2012) B. J. Heidinger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oxidative damage in multiple sclerosis lesions
- (2011) L. Haider et al. BRAIN
- Cancer and multiple sclerosis in the era of disease-modifying treatments
- (2011) Christine Lebrun et al. JOURNAL OF NEUROLOGY
- Age and disability accumulation in multiple sclerosis
- (2011) A. Scalfari et al. NEUROLOGY
- Evidence for a two-stage disability progression in multiple sclerosis
- (2010) E. Leray et al. BRAIN
- Thymic involution and proliferative T-cell responses in multiple sclerosis
- (2010) Danielle A. Duszczyszyn et al. JOURNAL OF NEUROIMMUNOLOGY
- Multiple sclerosis and risk of cancer: a meta-analysis
- (2010) A. E. Handel et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The changing demographic pattern of multiple sclerosis epidemiology
- (2010) Nils Koch-Henriksen et al. LANCET NEUROLOGY
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-related differences in integrin expression in peripheral blood lymphocytes
- (2010) Christine V Crooks et al. Immunity & Ageing
- Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
- (2009) Benjamin D. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL
- (2009) M. Hutchinson et al. JOURNAL OF NEUROLOGY
- Relapses in multiple sclerosis are age- and time-dependent
- (2008) H Tremlett et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
- (2008) M. Mehling et al. NEUROLOGY
- Comorbidity delays diagnosis and increases disability at diagnosis in MS
- (2008) R. A. Marrie et al. NEUROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started